328.24
price up icon3.23%   10.28
after-market After Hours: 331.45 3.21 +0.98%
loading
Medpace Holdings Inc stock is traded at $328.24, with a volume of 376.17K. It is up +3.23% in the last 24 hours and down -4.32% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$317.96
Open:
$316.2
24h Volume:
376.17K
Relative Volume:
1.13
Market Cap:
$10.20B
Revenue:
$2.03B
Net Income/Loss:
$339.79M
P/E Ratio:
38.44
EPS:
8.54
Net Cash Flow:
$502.80M
1W Performance:
-0.46%
1M Performance:
-4.32%
6M Performance:
-16.39%
1Y Performance:
+19.70%
1-Day Range:
Value
$315.39
$328.94
1-Week Range:
Value
$310.92
$331.99
52-Week Range:
Value
$268.16
$459.77

Medpace Holdings Inc Stock (MEDP) Company Profile

Name
Name
Medpace Holdings Inc
Name
Phone
(513) 579-9911
Name
Address
5375 MEDPACE WAY, CINCINNATI, OH
Name
Employee
5,900
Name
Twitter
@WorkatMedpace
Name
Next Earnings Date
2024-10-21
Name
Latest SEC Filings
Name
MEDP's Discussions on Twitter

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-14-24 Initiated Redburn Atlantic Buy
Sep-27-24 Downgrade UBS Buy → Neutral
Sep-25-24 Downgrade Jefferies Buy → Hold
Aug-01-24 Initiated Truist Hold
May-29-24 Initiated TD Cowen Buy
May-28-24 Initiated Mizuho Buy
Apr-23-24 Upgrade Jefferies Hold → Buy
Mar-18-24 Initiated Deutsche Bank Hold
Feb-15-24 Upgrade UBS Neutral → Buy
Oct-24-23 Upgrade Robert W. Baird Neutral → Outperform
May-08-23 Upgrade Guggenheim Neutral → Buy
Oct-27-22 Upgrade UBS Sell → Neutral
Sep-07-22 Initiated UBS Sell
May-24-22 Initiated Guggenheim Neutral
Aug-05-21 Resumed Credit Suisse Outperform
Oct-02-20 Upgrade Truist Hold → Buy
Jun-08-20 Upgrade Robert W. Baird Underperform → Neutral
May-13-20 Downgrade Wolfe Research Outperform → Peer Perform
Apr-30-20 Upgrade SunTrust Sell → Hold
Apr-20-20 Downgrade Robert W. Baird Neutral → Underperform
Mar-17-20 Downgrade SunTrust Hold → Sell
Jan-27-20 Downgrade SunTrust Buy → Hold
Oct-31-18 Upgrade SunTrust Hold → Buy
Sep-17-18 Initiated SunTrust Hold
Jul-31-18 Upgrade William Blair Mkt Perform → Outperform
Nov-01-17 Downgrade William Blair Outperform → Mkt Perform
Sep-29-17 Initiated Raymond James Mkt Perform
Jul-10-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
View All

Medpace Holdings Inc Stock (MEDP) Latest News

pulisher
02:49 AM

MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. F - GuruFocus.com

02:49 AM
pulisher
Nov 04, 2024

MEDP Investigation Notice: Kessler Topaz Meltzer & Check, LLP En - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

What Makes Medpace Holdings (MEDP) a Good Holding? - Insider Monkey

Nov 04, 2024
pulisher
Nov 04, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation - AccessWire

Nov 04, 2024
pulisher
Nov 02, 2024

Medpace Holdings, Inc. (NASDAQ:MEDP) Stake Lowered by Integrated Advisors Network LLC - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws - GlobeNewswire Inc.

Nov 01, 2024
pulisher
Nov 01, 2024

Medpace: A Compelling Long-Term Opportunity Amid Short-Term Headwinds (NASDAQ:MEDP) - Seeking Alpha

Nov 01, 2024
pulisher
Nov 01, 2024

Stephens Investment Management Group LLC Acquires 3,889 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Medpace cut to neutral by Baird, slowed revenue growth cited - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

abrdn plc Reduces Position in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws - AccessWire

Oct 30, 2024
pulisher
Oct 30, 2024

MEDP Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - PR Newswire

Oct 30, 2024
pulisher
Oct 30, 2024

International Assets Investment Management LLC Buys 57,265 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Bragar Eagel & Squire, P.C. Is Investigating Aviat, - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire

Oct 29, 2024
pulisher
Oct 29, 2024

Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

China Universal Asset Management Co. Ltd. Purchases 2,322 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Stockholders to Learn More About the Investigation - AccessWire

Oct 28, 2024
pulisher
Oct 28, 2024

Medpace: Long-Term Owners Have To Stomach Short-Term Volatility - Seeking Alpha

Oct 28, 2024
pulisher
Oct 27, 2024

Boston Trust Walden Corp Has $43.28 Million Position in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Oct 27, 2024
pulisher
Oct 26, 2024

Medpace: Buy The Short-Term Pain For Long-Term Gains (NASDAQ:MEDP) - Seeking Alpha

Oct 26, 2024
pulisher
Oct 26, 2024

Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Fraud Investigation with the Schall Law Firm - Marketscreener.com

Oct 25, 2024
pulisher
Oct 25, 2024

William Blair Issues Positive Outlook for Medpace Earnings - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Argent Capital Management LLC Increases Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

FY2024 Earnings Forecast for Medpace Issued By William Blair - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Medpace (NASDAQ:MEDP) Downgraded by Baird R W to Hold - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 24, 2024
pulisher
Oct 23, 2024

TD Cowen Trims Medpace (NASDAQ:MEDP) Target Price to $372.00 - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Medpace stock downgraded by Baird amid funding challenges & weaker growth outlook - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 23, 2024

NASDAQ: MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - PR Newswire

Oct 23, 2024
pulisher
Oct 23, 2024

Earnings call: Medpace reports growth amidst increased cancellations By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 23, 2024

Earnings call: Medpace reports growth amidst increased cancellations - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

Medpace Holdings, Inc. (NASDAQ:MEDP) Stock Position Raised by Lecap Asset Management Ltd. - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Medpace Q3 2024 Earnings Preview - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

Medpace (NASDAQ:MEDP) Cut to Neutral at Robert W. Baird - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Medpace downgraded to Neutral from Outperform at Baird - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

Medpace Holdings Inc (MEDP) Q3 2024 Earnings Call Highlights: Strong Revenue and Income Growth ... - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

TD Cowen maintains Buy rating on Medpace stock - Investing.com

Oct 23, 2024
pulisher
Oct 22, 2024

NASDAQ: MEDP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - Business Wire

Oct 22, 2024
pulisher
Oct 22, 2024

Medpace Earnings: Shares Fall Due to Cancellations From Biotech Funding Issues - Morningstar

Oct 22, 2024
pulisher
Oct 22, 2024

How Medpace Just Blew Up Expectations For Double-Digit Sales Growth In 2025 - MSN

Oct 22, 2024
pulisher
Oct 22, 2024

Medpace's (MEDP) "Outperform" Rating Reiterated at William Blair - MarketBeat

Oct 22, 2024
pulisher
Oct 22, 2024

Medpace (NASDAQ:MEDP) Shares Gap DownHere's Why - MarketBeat

Oct 22, 2024
pulisher
Oct 22, 2024

Medpace Stock Drop. Biotech’s Doldrums Are to Blame. - MSN

Oct 22, 2024
pulisher
Oct 22, 2024

Medpace Stock Drops. Biotech’s Doldrums Are to Blame. - Barron's

Oct 22, 2024
pulisher
Oct 22, 2024

TD Cowen maintains Buy rating on Medpace stock By Investing.com - Investing.com UK

Oct 22, 2024
pulisher
Oct 22, 2024

Medpace (NASDAQ:MEDP) Issues Quarterly Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat

Oct 22, 2024
pulisher
Oct 22, 2024

Medpace revenue increases 8.3% to USD 533.3M in Q3 2024 - Medical Buyer

Oct 22, 2024

Medpace Holdings Inc Stock (MEDP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
Cap:     |  Volume (24h):